Literature DB >> 22314521

Early endpoints for acute bacterial skin and skin structure infections.

George L Drusano1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22314521      PMCID： PMC3346651          DOI： 10.1128/AAC.00157-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  5 in total

1.  Frequentist and Bayesian pharmacometric-based approaches to facilitate critically needed new antibiotic development: overcoming lies, damn lies, and statistics.

Authors:  Paul G Ambrose; Jeffrey P Hammel; Sujata M Bhavnani; Christopher M Rubino; Evelyn J Ellis-Grosse; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

2.  Sulphanilamide in the Treatment of Erysipelas.

Authors:  W R Snodgrass; T Anderson
Journal:  Br Med J       Date:  1937-12-11

3.  Prontosil in Erysipelas.

Authors:  W R Snodgrass; T Anderson
Journal:  Br Med J       Date:  1937-07-17

4.  CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.

Authors:  H David Friedland; Tanya O'Neal; Donald Biek; Paul B Eckburg; Douglas R Rank; Lily Llorens; Alex Smith; Gary W Witherell; Joseph B Laudano; Dirk Thye
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

5.  Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection.

Authors:  G Ralph Corey; Mark Wilcox; George H Talbot; H David Friedland; Tanya Baculik; Gary W Witherell; Ian Critchley; Anita F Das; Dirk Thye
Journal:  Clin Infect Dis       Date:  2010-09-15       Impact factor: 9.079
  5 in total
  2 in total

1.  Editorial Commentary: A Collaborative Model for Endpoint Development: Advancing the Science of Antibacterial Drug Clinical Trials.

Authors:  Joseph G Toerner; Edward Cox
Journal:  Clin Infect Dis       Date:  2015-12-13       Impact factor: 9.079

2.  Treatment outcome measures for randomized controlled trials of antibiotic treatment for acute bacterial skin and skin structure infections in the emergency department setting.

Authors:  Michael Quirke; Abel Wakai
Journal:  Int J Emerg Med       Date:  2015-04-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.